CELGENE CORP /DE/

Insider Buys Quantity –
2
2020-07-09SaleBristol-Myers Squibb Company
BMY
10 percent owner
2,241
0.0002%
$102.28$229,209+8.18%
2020-07-01PurchaseBristol-Myers Squibb Company
BMY
10 percent owner
108,108
0.0075%
$92.50$10M+6.23%
2018-11-21SaleCRISPR Therapeutics AG
CRSP
10 percent owner
160,000
0.1832%
$19.25$3.08M+11.49%
2017-12-04SaleCRISPR Therapeutics AG
CRSP
10 percent owner
60,970
0.1623%
$19.47$1.19M+159.26%
2017-12-01SaleCRISPR Therapeutics AG
CRSP
10 percent owner
175,982
0.4389%
$19.10$3.36M+147.96%
2017-11-30SaleCRISPR Therapeutics AG
CRSP
10 percent owner
25,332
0.0634%
$19.04$482,321+149.29%
2017-11-29SaleCRISPR Therapeutics AG
CRSP
10 percent owner
8,526
0.022%
$19.25$164,126+153.7%
2017-11-28SaleCRISPR Therapeutics AG
CRSP
10 percent owner
10,160
0.0254%
$19.22$195,275+146.43%
2017-11-27SaleCRISPR Therapeutics AG
CRSP
10 percent owner
55,980
0.1412%
$19.75$1.11M+142.15%
2017-11-24SaleCRISPR Therapeutics AG
CRSP
10 percent owner
52,020
0.1297%
$20.00$1.04M+136.81%
2017-11-22SaleCRISPR Therapeutics AG
CRSP
10 percent owner
512,000
1.2749%
$19.76$10.12M+139.32%
2017-11-20SaleCRISPR Therapeutics AG
CRSP
10 percent owner
317,436
0.7916%
$19.02$6.04M+148.63%
2017-11-17SaleCRISPR Therapeutics AG
CRSP
10 percent owner
102,564
0.254%
$18.44$1.89M+155.03%
2017-11-16SaleCRISPR Therapeutics AG
CRSP
10 percent owner
210,000
0.5234%
$18.39$3.86M+157%
2017-11-15SaleCRISPR Therapeutics AG
CRSP
10 percent owner
30,000
0.0749%
$17.67$530,100+168.06%
2017-11-14SaleCRISPR Therapeutics AG
CRSP
10 percent owner
29,814
0.0733%
$17.19$512,503+171.13%
2017-11-13SaleCRISPR Therapeutics AG
CRSP
10 percent owner
130,186
0.3252%
$17.76$2.31M+166.7%
2017-11-10SaleCRISPR Therapeutics AG
CRSP
10 percent owner
20,000
0.0494%
$17.28$345,600+171.69%
2017-11-09SaleCRISPR Therapeutics AG
CRSP
10 percent owner
40,000
0.1006%
$17.08$683,200+179.29%
2017-11-08SaleCRISPR Therapeutics AG
CRSP
10 percent owner
33,750
0.0848%
$18.06$609,525+163.88%